BioGaia Zukünftiges Wachstum
Future Kriterienprüfungen 2/6
BioGaia wird ein Gewinn- und Umsatzwachstum von 10.2% bzw. 11.8% pro Jahr prognostiziert, während der Gewinn pro Aktie um 10.2% pro Jahr wachsen soll.
Wichtige Informationen
10.2%
Wachstumsrate der Gewinne
10.2%
EPS-Wachstumsrate
Biotechs Gewinnwachstum | 39.1% |
Wachstumsrate der Einnahmen | 11.8% |
Zukünftige Eigenkapitalrendite | n/a |
Analystenabdeckung | Low |
Zuletzt aktualisiert | 10 Jun 2024 |
Jüngste Aktualisierungen zum künftigen Wachstum
Recent updates
BioGaia (STO:BIOG B) Has Announced That It Will Be Increasing Its Dividend To SEK6.90
Apr 25BioGaia's (STO:BIOG B) Shareholders Will Receive A Bigger Dividend Than Last Year
Apr 09BioGaia (STO:BIOG B) Has Announced That It Will Be Increasing Its Dividend To SEK6.90
Mar 26BioGaia (STO:BIOG B) Will Pay A Larger Dividend Than Last Year At SEK6.90
Mar 09BioGaia (STO:BIOG B) Has Announced That It Will Be Increasing Its Dividend To SEK6.90
Feb 24BioGaia's (STO:BIOG B) Upcoming Dividend Will Be Larger Than Last Year's
Feb 10Here's Why We Think BioGaia (STO:BIOG B) Might Deserve Your Attention Today
Nov 27Calculating The Intrinsic Value Of BioGaia AB (publ) (STO:BIOG B)
Sep 13Does BioGaia (STO:BIOG B) Deserve A Spot On Your Watchlist?
Jun 02A Look At The Intrinsic Value Of BioGaia AB (publ) (STO:BIOG B)
Apr 27Do BioGaia's (STO:BIOG B) Earnings Warrant Your Attention?
Jan 14Do BioGaia's (STO:BIOG B) Earnings Warrant Your Attention?
Aug 26Does This Valuation Of BioGaia AB (publ) (STO:BIOG B) Imply Investors Are Overpaying?
Jul 24Calculating The Intrinsic Value Of BioGaia AB (publ) (STO:BIOG B)
Apr 02BioGaia's (STO:BIOG B) Shareholders Will Receive A Bigger Dividend Than Last Year
Feb 21Need To Know: Analysts Are Much More Bullish On BioGaia AB (publ) (STO:BIOG B) Revenues
Feb 09BioGaia's (STO:BIOG B) Upcoming Dividend Will Be Larger Than Last Year's
Feb 07Some Shareholders May find It Hard To Increase BioGaia AB (publ)'s (STO:BIOG B) CEO Compensation This Year
Apr 29Key Things To Consider Before Buying BioGaia AB (publ) (STO:BIOG B) For Its Dividend
Mar 25The BioGaia (STO:BIOG B) Share Price Is Up 90% And Shareholders Are Holding On
Mar 04CEO & President Isabelle Valerie Ducellier Just Bought 8.2% More Shares In BioGaia AB (publ) (STO:BIOG B)
Feb 11Is BioGaia AB (publ)'s (STO:BIOG B) Latest Stock Performance A Reflection Of Its Financial Health?
Jan 26What Type Of Shareholders Own The Most Number of BioGaia AB (publ) (STO:BIOG B) Shares?
Jan 11How Much Are BioGaia AB (publ) (STO:BIOG B) Insiders Taking Off The Table?
Dec 27Read This Before Buying BioGaia AB (publ) (STO:BIOG B) For Its Dividend
Dec 13BioGaia (STO:BIOG B) Shareholders Have Enjoyed A 57% Share Price Gain
Nov 28Gewinn- und Umsatzwachstumsprognosen
Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
---|---|---|---|---|---|
12/31/2025 | 1,600 | 446 | N/A | N/A | 1 |
12/31/2024 | 1,441 | 413 | N/A | N/A | 1 |
3/31/2024 | 1,300 | 371 | 323 | 379 | N/A |
12/31/2023 | 1,297 | 365 | 377 | 426 | N/A |
9/30/2023 | 1,273 | 437 | 361 | 396 | N/A |
6/30/2023 | 1,213 | 415 | 311 | 342 | N/A |
3/31/2023 | 1,186 | 413 | 310 | 324 | N/A |
12/31/2022 | 1,104 | 374 | 301 | 319 | N/A |
9/30/2022 | 1,036 | 273 | 262 | 284 | N/A |
6/30/2022 | 952 | 246 | 286 | 305 | N/A |
3/31/2022 | 867 | 222 | 263 | 273 | N/A |
12/31/2021 | 785 | 196 | 215 | 222 | N/A |
9/30/2021 | 767 | 196 | 215 | 220 | N/A |
6/30/2021 | 725 | 164 | 201 | 208 | N/A |
3/31/2021 | 766 | 188 | 177 | 190 | N/A |
12/31/2020 | 747 | 180 | 205 | 221 | N/A |
9/30/2020 | 767 | 194 | 155 | 184 | N/A |
6/30/2020 | 802 | 211 | 155 | 189 | N/A |
3/31/2020 | 780 | 193 | 147 | 185 | N/A |
12/31/2019 | 768 | 187 | 109 | 148 | N/A |
9/30/2019 | 770 | 192 | 133 | 160 | N/A |
6/30/2019 | 778 | 205 | 152 | 174 | N/A |
3/31/2019 | 756 | 207 | 161 | 176 | N/A |
12/31/2018 | 742 | 215 | 170 | 183 | N/A |
9/30/2018 | 702 | 206 | 211 | 223 | N/A |
6/30/2018 | 675 | 197 | 176 | 192 | N/A |
3/31/2018 | 631 | 181 | 158 | 181 | N/A |
12/31/2017 | 615 | 181 | N/A | 223 | N/A |
9/30/2017 | 584 | 179 | N/A | 201 | N/A |
6/30/2017 | 562 | 172 | N/A | 210 | N/A |
3/31/2017 | 542 | 163 | N/A | 198 | N/A |
12/31/2016 | 535 | 160 | N/A | 148 | N/A |
9/30/2016 | 500 | 138 | N/A | 115 | N/A |
6/30/2016 | 480 | 129 | N/A | 86 | N/A |
3/31/2016 | 478 | 130 | N/A | 108 | N/A |
12/31/2015 | 483 | 138 | N/A | 118 | N/A |
9/30/2015 | 500 | 130 | N/A | 100 | N/A |
6/30/2015 | 474 | 119 | N/A | 67 | N/A |
3/31/2015 | 432 | 97 | N/A | 55 | N/A |
12/31/2014 | 482 | 147 | N/A | 124 | N/A |
9/30/2014 | 451 | 146 | N/A | 126 | N/A |
6/30/2014 | 433 | 145 | N/A | 163 | N/A |
3/31/2014 | 426 | 142 | N/A | 167 | N/A |
12/31/2013 | 316 | 62 | N/A | 78 | N/A |
9/30/2013 | 298 | 60 | N/A | 57 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: BIOG BDas prognostizierte Gewinnwachstum (10.2% pro Jahr) liegt über der Sparquote (1%).
Ertrag vs. Markt: BIOG BDie Erträge des Unternehmens (10.2% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt Swedish (14.1% pro Jahr).
Hohe Wachstumserträge: BIOG BDie Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.
Einnahmen vs. Markt: BIOG BDie Einnahmen des Unternehmens (11.8% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Swedish (1.8% pro Jahr).
Hohe Wachstumseinnahmen: BIOG BDie Einnahmen des Unternehmens (11.8% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: Unzureichende Daten, um festzustellen, ob die Eigenkapitalrendite von BIOG B in 3 Jahren voraussichtlich hoch sein wird